Table 4.
Hazard ratio for in-hospital death | 95% CI | p value | Hazard ratio for death within 1 year | 95% CI | p value | |
Age | 0.068 | 0.005 | ||||
18–64 years | 1 | 1 | ||||
≥65 years | 1.72 | 1.0–3.03 | 2.17 | 1.27–3.70 | ||
Sex | 0.426 | 0.707 | ||||
Female | 1 | 1 | ||||
Male | 1.32 | 0.67–2.60 | 1.12 | 0.61–2.10 | ||
Etiology | 0.060b | 0.066b | ||||
Staphylococcus aureus | 1 | 1 | ||||
CoNSc | 0.87 | 0.33–2.26 | 0.93 | 0.36–2.40 | ||
Viridans streptococci | 0.90 | 0.40–2.03 | 0.85 | 0.40–1.81 | ||
Enterococcus faecalis | 0.36 | 0.08–1.57 | 0.55 | 0.16–1.90 | ||
Streptococcus pneumoniae | 2.37 | 0.85–6.59 | 2.58 | 0.94–7.09 | ||
Other pathogens | 0.35 | 0.08–1.54 | 0.31 | 0.07–1.36 | ||
Culture negative | 0.42 | 0.17–1.05 | 0.51 | 0.23–1.13 | ||
Affected valves | <0.001b | <0.001b | ||||
Prosthetic | 1 | 1 | ||||
Aortic | 1.13 | 0.48–2.65 | 1.01 | 0.46–2.19 | ||
Mitral | 0.45 | 0.16–1.31 | 0.60 | 0.24–1.47 | ||
Tricuspid | 1.04 | 0.22–4.88 | 0.73 | 0.16–3.35 | ||
Two native valves | 3.55 | 1.49–8.47 | 3.75 | 1 68–8.34 | ||
Echocardiography | ||||||
Major Criterion | 0.346 | 0.015 | ||||
No | 1 | 1 | ||||
Yes | 1.43 | 0. 68–3.00 | 2.44 | 0.19–5.0 | ||
Vegetation | 0.102 | 0.005 | ||||
No | 1. | 1 | ||||
Yes | 1.81 | 0.90–3.68 | 2.62 | 1.35–5.09 | ||
Neurological complicationsd | 0.009 | 0.003 | ||||
No | 1 | 1 | ||||
Yes | 2.17 | 1.21–3.90 | 2.30 | 1.34–3.96 | ||
Peripheral embolid | 0.036 | 0.016 | ||||
No | 1 | 1 | ||||
Yes | 1.86 | 1.04–3.33 | 1.95 | 1.14–3.35 | ||
Heart failured | <0.001 | <0.001 | ||||
No | 1 | 1 | ||||
Yes | 5.98 | 2.35–15.17 | 7.62 | 3.26–17.83 | ||
Serum CRP on admission | 0.008 | <0.001 | ||||
< 100 mg/l | 1 | 1 | ||||
≥100 mg/l | 2.92 | 1.33–6.40 | 3.90 | 1.81–8.43 |
aMean (SD) duration of in-hospital treatment was 55 (33), range 4 to 272 days; bp values for overall group differences; ccoagulase-negative staphylococci; dwithin 3 months from admission